BCTG Acquisition (BCTG) Stock Price, News & Analysis

Company Overview

BCTG Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses primarily located in North America and Europe in the biotechnology industry. The company was incorporated in 2020 and is based in San Diego, California.

Key Stats

• Today's Range: N/A
• 50-Day Range: $9.88 to $11.47
• 52-Week Range: N/A
• Volume: 2,024 shs
• Average Volume: 36,697 shs
• Market Capitalization: $218.05 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BCTG Stock Analysis - Frequently Asked Questions

When did BCTG Acquisition IPO?

BCTG Acquisition (BCTG) raised $145 million in an initial public offering (IPO) on Thursday, September 3rd 2020. The company issued 14,500,000 shares at a price of $10.00 per share. SVB Leerink served as the underwriter for the IPO.

What other stocks do shareholders of BCTG Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BCTG Acquisition investors own include Churchill Capital Corp IV (CCIV), Great Elm Capital Group (GECC), Gores Holdings IV (GHIV), Mastech Digital (MHH), Mirati Therapeutics (MRTX), Novus Capital (NOVS) and CC Neuberger Principal Holdings II (PRPB).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:BCTG
• CIK: N/A
• Web: N/A
• Phone: 858-400-3112
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.80
• Quick Ratio: 4.80

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.23 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 21,377,000
• Free Float: N/A
• Market Cap: $218.05 million
• Optionable: Not Optionable
• Beta: N/A